MADRIGAL PHARMACEUTICALS, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-13
Book Value Per Share
$27
Free Cash Flow Per Share
$-8
Cash Per Share
$9
Revenue Per Share
$43
OCF Per Share
$-8
Return on Equity
-42.5%
Return on Assets
-25.0%
Return on Invested Capital
-26.1%
Debt to Equity
0.56
Current Ratio
4.01
Quick Ratio
3.77
Asset Turnover
0.83
Days Sales Outstanding
51.21
Days Payables Outstanding
2553.13
Days Inventory On Hand
1995.00
Cash Conversion Cycle
-449.07
R&D / Revenue
40.5%
SBC / Revenue
10.2%
Capex / Revenue
0.0%
Working Capital
$935M
Net Current Asset Value
$589M
Invested Capital
$943M
OCF / Net Income
0.66
FCF / Net Income
0.66
Accruals Ratio (Sloan)
-7.8%
Net Debt
$141M
Net Debt / EBITDA
-0.47
Interest Coverage
-13.45
Cash Coverage
-8.50
Capex Coverage
-405.90
Tangible Common Equity
$595M
TCE / Total Assets
47.3%
NOPAT
$-237M
Cash ROIC
-20.9%
WC / Revenue
97.6%
Capex / D&A
0.31
Reinvestment Rate
0.3%
Total Payout Ratio
—
Asset Growth vs Revenue Growth
-411.2%
Book Value 5Y CAGR
20.2%
Stock Price (FY-end)
$582
Market Cap
$13.06B
P/S Ratio
13.63
P/B Ratio
21.68
P/TB Ratio
21.95
Enterprise Value
$13.21B
EV / Sales
13.78
FCF Yield
-1.5%
Shareholder Yield
-0.8%
R&D Yield
3.0%
Capex Yield
0.0%
Graham Number
—
Shares Variation (YoY)
5.5%
Beta (5Y)
0.79
Cost of Equity
8.5%
Cost of Debt (after tax)
5.2%
52W High
$603
52W Low
$268
Trailing Return 1Y
86.0%
Trailing Return 5Y
395.4%
F-Score (Piotroski)
3.00
Z-Score (Altman)
10.48
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.